Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghong Zou

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 31, 2017
Corrigendum to 'Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathy' [Biochimica et Biophysica Acta 1863/6 (2017) 1264-1272]Honghong Zou, Guoqing Wu, Jinlei Lv, et al.
Kidney International Reports|July 11, 2018
Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled TrialsPingping Yang, Honghong Zou, Bufan Xiao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 2, 2017
Corrigendum to "Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathy" [BBA - Molecular Basis of Disease Vol.1863/Iss.6(2017) 1264-1272]Honghong Zou, Guoqing Wu, Jinlei Lv, et al.
Clinical and Experimental Medicine|September 9, 2024
The efficacy of rituximab in the treatment of IgA vasculitis nephritisYi Xiong, Santiago Cuevas, Gaosi Xu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 10, 2017
Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathyHonghong Zou, Guoqing Wu, Jinlei Lv, et al.
Journal of Hypertension|September 23, 2025
Role of E2F1 , taking account for the transcriptional activity of lncRNA HOTAIR , in vascular calcification via epigenetic silencing of KLF16/KlothoYanxia Chen, Ben Ke, Minzi Qiu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 17, 2025
Dapagliflozin in diabetic kidney disease patients with different filtration statusYang Yang, Manna Li, Honghong Zou, et al.
BMC Nephrology|October 15, 2025
Efficacy and safety of hydroxychloroquine in IgA nephropathy with nasopharyngeal or intestinal mucosal and non-mucosal infectionsRan Zhang, Yang Yang, Yan Yan, et al.
American Journal of Translational Research|September 15, 2022
A pedigree with <i>COL4A5</i> mutation presenting with Alport syndrome and focal segmental glomerulosclerosis lesions: a case reportHonghong Zou, Li Zhu, Rong Xu, et al.
EMBO Molecular Medicine|October 14, 2025
Glycine decarboxylase advances IgA nephropathy by boosting mesangial cell proliferation through the pyrimidine pathwayYi Xiong, Fang Zeng, Kaiping Luo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 31, 2017
Corrigendum to 'Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathy' [Biochimica et Biophysica Acta 1863/6 (2017) 1264-1272]Honghong Zou, Guoqing Wu, Jinlei Lv, et al.
Kidney International Reports|July 11, 2018
Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled TrialsPingping Yang, Honghong Zou, Bufan Xiao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 2, 2017
Corrigendum to "Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathy" [BBA - Molecular Basis of Disease Vol.1863/Iss.6(2017) 1264-1272]Honghong Zou, Guoqing Wu, Jinlei Lv, et al.
Clinical and Experimental Medicine|September 9, 2024
The efficacy of rituximab in the treatment of IgA vasculitis nephritisYi Xiong, Santiago Cuevas, Gaosi Xu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 10, 2017
Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathyHonghong Zou, Guoqing Wu, Jinlei Lv, et al.
Journal of Hypertension|September 23, 2025
Role of E2F1 , taking account for the transcriptional activity of lncRNA HOTAIR , in vascular calcification via epigenetic silencing of KLF16/KlothoYanxia Chen, Ben Ke, Minzi Qiu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 17, 2025
Dapagliflozin in diabetic kidney disease patients with different filtration statusYang Yang, Manna Li, Honghong Zou, et al.
BMC Nephrology|October 15, 2025
Efficacy and safety of hydroxychloroquine in IgA nephropathy with nasopharyngeal or intestinal mucosal and non-mucosal infectionsRan Zhang, Yang Yang, Yan Yan, et al.
American Journal of Translational Research|September 15, 2022
A pedigree with <i>COL4A5</i> mutation presenting with Alport syndrome and focal segmental glomerulosclerosis lesions: a case reportHonghong Zou, Li Zhu, Rong Xu, et al.
EMBO Molecular Medicine|October 14, 2025
Glycine decarboxylase advances IgA nephropathy by boosting mesangial cell proliferation through the pyrimidine pathwayYi Xiong, Fang Zeng, Kaiping Luo, et al.
Pageof 3